Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. | EVP, CFO | Common Stock | 24.8K | $164K | $6.63 | Aug 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATRA | Atara Biotherapeutics, Inc. | Aug 16, 2024 | 2 | -$7.09K | 4 | Aug 20, 2024 | EVP, CFO |
ATRA | Atara Biotherapeutics, Inc. | May 16, 2024 | 1 | -$17.7K | 4 | May 20, 2024 | EVP, CFO |
ATRA | Atara Biotherapeutics, Inc. | Mar 4, 2024 | 2 | -$4.81K | 4 | Mar 6, 2024 | EVP, CFO |
ATRA | Atara Biotherapeutics, Inc. | Jan 8, 2024 | 1 | $0 | 4 | Jan 9, 2024 | EVP, CFO |
ATRA | Atara Biotherapeutics, Inc. | Nov 16, 2023 | 1 | -$4.65K | 4 | Nov 20, 2023 | SVP, CFO |
ATRA | Atara Biotherapeutics, Inc. | Aug 16, 2023 | 2 | -$13.5K | 4 | Aug 18, 2023 | SVP, CFO |
ATRA | Atara Biotherapeutics, Inc. | May 16, 2023 | 2 | -$16.1K | 4 | May 18, 2023 | SVP, CFO |
ATRA | Atara Biotherapeutics, Inc. | Apr 1, 2023 | 0 | $0 | 3 | Apr 7, 2023 | SVP, CFO |